Literature DB >> 4376515

Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.

R Vánky, E Klein, J Stjernswärd, U Nilsonne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4376515     DOI： 10.1002/ijc.2910140217

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  8 in total

1.  Tumour-associated antigens.

Authors:  R W Baldwin
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

2.  Expression of interleukin-2 receptor on blood lymphocytes stimulated with allogeneic lymphocytes or autologous tumor cells. The mixed lymphocyte culture of allo-sensitized individuals and the auto-tumor stimulation show similar kinetics of activation.

Authors:  G Stuber; F Vánky; E Pócsik; M Benczúr; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Human malignant melanoma antigenic properties of phenol water extracts.

Authors:  L Suter; H Tilkorn; P M Kövary
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

4.  The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

Authors:  E A Grimm; B M Vose; E W Chu; D J Wilson; M T Lotze; A A Rayner; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes.

Authors:  F Vánky; C Hising; K Sjöwall; B Larsson; L Rodriguez; L Orre; E Klein
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

6.  Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates.

Authors:  M E Ludgate; J Gough
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

7.  Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.

Authors:  J T Frbes; Y Nakaw; R T Smith
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

8.  Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.

Authors:  M B Calderwood; J T Forbes; R T Smith
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.